AKTX vs KYMR
Akari Therapeutics, Plc · Kymera Therapeutics, Inc.
Relative return (rebased to 100)
Key stats
| Metric | AKTX | KYMR |
|---|---|---|
| Price | $10.70 | $118.15 |
| Market Cap | $979.77B | $9.72B |
| P/E | — | — |
| P/B | 68134.01 | 6.31 |
| P/S | 2663300.51 | 247.86 |
| ROE | -120.3% | -20.2% |
| Net Margin | -4702.1% | -794.0% |
| Gross Margin | — | — |
| Revenue Growth | -39.5% | -16.7% |
| Dividend Yield | — | — |
| EPS | -$0.00 | -$3.79 |
Metrics from owned fundamentals, updated daily. Highlighted values are the more favorable of the two.